{
    "organizations": [],
    "uuid": "230729b612dffae427f0b6662b64ec1ad493f327",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-basilea-pharmaceutica-reports-laun/brief-basilea-pharmaceutica-reports-launch-of-antibiotic-zevtera-in-saudi-arabia-idUSFWN1SL1AD",
    "ord_in_thread": 0,
    "title": "BRIEF-Basilea Pharmaceutica Reports Launch Of Antibiotic Zevtera In Saudi Arabia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - BASILEA PHARMACEUTICA AG:\n* REPORTS LAUNCH OF ANTIBIOTIC ZEVTERA (CEFTOBIPROLE) IN SAUDI ARABIA BY HIKMA PHARMACEUTICALS LLC Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T13:23:00.000+03:00",
    "crawled": "2018-05-16T19:19:04.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "basilea",
        "pharmaceutica",
        "ag",
        "report",
        "launch",
        "antibiotic",
        "zevtera",
        "ceftobiprole",
        "saudi",
        "arabia",
        "hikma",
        "pharmaceutical",
        "llc",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}